Sai Parenteral's Limited (NSE:SAIPARENT)
India flag India · Delayed Price · Currency is INR
547.50
+12.55 (2.35%)
At close: Jul 31, 2026

Sai Parenteral's Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
3,8103,8101,6311,538967.96
Revenue Growth
-133.59%6.08%58.85%-
Gross Profit
1,3881,388692.55588.19389.53
Operating Income
218.46218.46317.03221.69138.13
Net Income
142.59142.59144.5484.1543.76
Earnings Per Share
4.364.365.435.253.07
EPS Growth
--19.71%3.50%70.86%-

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023
Period EndingMar '25 Mar '24 Mar '23
Branded Generic Formulations
1,2731,311914.79
CDMO Products and Services
312.46187.3753.17
Total
1,5851,498967.96

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
4,1704,17029.0852.169.82
Total Debt
2,4292,429939.541,188685.47
Net Cash (Debt)
1,7411,741-910.46-1,136-675.65
Net Cash Growth
-----
Net Cash Per Share
53.2253.22-34.21-70.80-47.41

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
930.51930.51331.49-297.64-127.99
Capital Expenditures
-2,300-2,300-5-350.69-157.41
Free Cash Flow
-1,369-1,369326.49-648.33-285.4
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
36.42%36.42%42.46%38.25%40.24%
Operating Margin
5.73%5.73%19.44%14.42%14.27%
Pretax Margin
3.13%3.13%12.21%8.16%7.49%
Profit Margin
3.74%3.74%8.86%5.47%4.52%
FCF Margin
-35.93%-35.93%20.02%-42.16%-29.48%